Full profile

Also known asCholecalciferol
Best forFoundational nutritional support · Correcting or preventing low vitamin D status · Northern-latitude, low-sun populations
Evidence gradeGrade C — Limited — early or small human trials
Studied dose range1,000–2,000 IU (25–50 mcg) daily for maintenance; up to the 4,000 IU (100 mcg) adult upper limit under guidance. Canadian non-prescription monograph routes cap lower — see label tips.
Time to effectNot acute; serum levels rise over roughly 6–12 weeks of daily use.
Best formD3 (cholecalciferol) over D2; take with a fat-containing meal for absorption.
Food sourcesFatty fish (salmon, mackerel, sardines), Cod liver oil, Egg yolks, UV-exposed mushrooms, Fortified milk and plant milks

Evidence, honestly graded

For its own roles (bone, calcium, immune) the evidence is strong, but for cognition specifically it is weak: a 24-trial meta-analysis found only a small global-cognition effect concentrated in deficient groups, and RCTs in replete healthy adults show no cognitive benefit. Graded C for the cognition angle only.

See the full grading rubric — study type, replication, population match, and dose adequacy — in The Evidence Standard.

276 licensed natural health products in Health Canada's LNHPD list Vitamin D3 as a medicinal ingredient.

That makes Vitamin D3 a recognized, licensable medicinal ingredient in Canada — regulated by Health Canada's Natural and Non-prescription Health Products Directorate, which issues each licensed natural health product a Natural Product Number (NPN). Search the LNHPD to verify.

Source: Health Canada Licensed Natural Health Products Database, snapshot 2026-07-26 — a count of licensed products, not an endorsement of any health claim. This describes the ingredient's regulatory standing in Canada, not Signal State Core, which is a pre-launch concept and is not a licensed natural health product.

Side effects

  • Very well tolerated at supplemental doses
  • Toxicity is rare and only at chronic high intakes (hypercalcemia)

Who should avoid it or check first

  • Hypercalcemia, hyperparathyroidism, or sarcoidosis
  • Kidney stones or significant renal impairment
  • Known vitamin D hypersensitivity

Interactions

  • May interact with thiazide diuretics, high-dose calcium, and digoxin — discuss with a clinician

Stacks well with

Use caution stacking with

  • Avoid high combined doses with separate calcium supplements without review

What to look for on a label

  • State both IU and micrograms (e.g. "1,000 IU (25 mcg)") since labels increasingly lead with mcg.
  • Respect the 4,000 IU (100 mcg) adult upper limit and add a "do not exceed" statement.
  • D3 works alongside two cofactors worth knowing about: magnesium is required to activate vitamin D in the body, and vitamin K2 (MK-7) works downstream of D to help direct the calcium it helps you absorb toward bone rather than soft tissue — see the Vitamin K2 (MK-7) entry and "Vitamin D and K2" article for the full picture. K2 interacts with warfarin and other blood thinners, so that combination needs a clear label warning.

References

  • Chen 2024, Neuropsychology Review — meta-analysis (24 RCTs). Small global-cognition effect across 24 RCTs / 7,557 people, concentrated in deficient groups. PMID 37418225; doi:10.1007/s11065-023-09598-z. Educational, not a product claim.
  • Health Canada NNHPD Vitamin D monograph. Permits bone/immune/good-health claims, not cognition. webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/1175. Confirm current version (NHP monographs updated effective 2026-03-27) before filing.

Entries above without a linked identifier are either editorial summaries of a wider body of literature or references to a named authority (a regulator or government monograph) cited by name rather than by a single paper.

Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.

Revision history

Every change to this ingredient's evidence status, dated and explained. The full cross-library log lives at Evidence Updates.

  • 2026-07-08New profile

    Initial profile published at Grade C for cognition specifically: a 24-trial meta-analysis found only a small effect concentrated in deficient groups, with no cognitive lift in replete adults; its bone, calcium, and immune roles grade stronger separately.

See how Vitamin D3 compares on grade, dose, and goal in the Evidence Explorer.